HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.

AbstractOBJECTIVE:
To examine the relationship between asymmetric dimethylarginine (ADMA) and HIV-associated pulmonary arterial hypertension (PAH).
DESIGN:
HIV infection is an independent risk factor for PAH, but the underlying pathogenesis remains unclear. Chronic inflammation resulting in nitric oxide-mediated endothelial dysfunction is a key mechanism underlying other types of PAH. ADMA is an endogenous inhibitor of endothelial nitric oxide synthase. Among uninfected individuals, ADMA is associated with PAH and predicts disease-related mortality.
METHODS:
We measured ADMA, high sensitivity C-reactive protein, interleukin-6 (IL-6), D-dimer, and pulmonary artery systolic pressure (PASP) using echocardiography in HIV-infected individuals. Right heart catheterization (RHC) was performed in individuals with a PASP at least 30  mmHg. We performed multivariable analysis to identify factors associated with high PASP by echocardiogram and PAH by RHC.
RESULTS:
Among 214 HIV-infected individuals, the median age was 50 years, 82% were men, 71% were on antiretroviral therapy, and 4.2% carried a prior diagnosis of PAH. ADMA and IL-6 were associated with increased values of PASP following multivariable adjustment (7.2% per 0.1 μmol/l, P = 0.0049 and 3.9% per doubling, P = 0.027, respectively). In adjusted analysis among the 85 participants who underwent RHC, ADMA and IL-6 were associated with higher values of mean PAP (14.2% per 0.1 μmol/l, P = 0.0014 and 5.8% per doubling, P = 0.038, respectively). However, only ADMA was associated with PAH (prevalence ratio = 1.74, P = 0.029).
CONCLUSION:
Elevated levels of ADMA are independently associated with PAH among HIV-infected individuals. Our findings suggest that chronic HIV-associated inflammation leading to an accumulation of ADMA and subsequent nitric oxide-mediated endothelial dysfunction may represent a novel mechanism for HIV-associated PAH.
AuthorsRushi V Parikh, Rebecca Scherzer, Elaine M Nitta, Anna Leone, Sophia Hur, Vanita Mistry, John S Macgregor, Jeffrey N Martin, Steven G Deeks, Peter Ganz, Priscilla Y Hsue
JournalAIDS (London, England) (AIDS) Vol. 28 Issue 4 Pg. 511-9 (Feb 20 2014) ISSN: 1473-5571 [Electronic] England
PMID24469026 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • N,N-dimethylarginine
  • Arginine
Topics
  • Adult
  • Arginine (analogs & derivatives, blood)
  • Biomarkers (blood)
  • Blood Pressure
  • Catheterization, Swan-Ganz
  • Cohort Studies
  • Echocardiography
  • Familial Primary Pulmonary Hypertension
  • Female
  • HIV Infections (complications)
  • Humans
  • Hypertension, Pulmonary (diagnosis, pathology)
  • Male
  • Middle Aged
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: